Edelstein M - Search Results

1

Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated sponges.

Amagata T, Johnson TA, Cichewicz RH, Tenney K, Mooberry SL, Media J, Edelstein M, Valeriote FA, Crews P. Amagata T, et al. Among authors: edelstein m. J Med Chem. 2008 Nov 27;51(22):7234-42. doi: 10.1021/jm8008585. J Med Chem. 2008. PMID: 18942825 Free PMC article.

2

Alteration of the bis-tetrahydrofuran core stereochemistries in asimicin can affect the cytotoxicity.

Sinha SC, Chen Z, Huang ZZ, Nakamaru-Ogiso E, Pietraszkiewicz H, Edelstein M, Valeriote F. Sinha SC, et al. Among authors: edelstein m. J Med Chem. 2008 Nov 27;51(22):7045-8. doi: 10.1021/jm801028c. J Med Chem. 2008. PMID: 18975929 Free PMC article.

3

Discovery and development of anticancer agents from marine sponges: perspectives based on a chemistry-experimental therapeutics collaborative program.

Valeriote FA, Tenney K, Media J, Pietraszkiewicz H, Edelstein M, Johnson TA, Amagata T, Crews P. Valeriote FA, et al. Among authors: edelstein m. J Exp Ther Oncol. 2012;10(2):119-34. J Exp Ther Oncol. 2012. PMID: 23350352

4

The role of cell kinetics in cancer chemotherapy.

Valeriote FA, Edelstein MB. Valeriote FA, et al. Among authors: edelstein mb. Semin Oncol. 1977 Jun;4(2):217-26. Semin Oncol. 1977. PMID: 327554 Review. No abstract available.

5

In vitro screening model for the detection of agents active against myelogenous leukemia.

Edelstein M, Corbett T, Valeriote F. Edelstein M, et al. Cancer Invest. 1998;16(5):303-8. doi: 10.3109/07357909809084648. Cancer Invest. 1998. PMID: 9627676

6

Retention of 1-beta-D-arabinofuranosylcytosine in vitro--a source of experimental error.

Edelstein M, Valeriote F. Edelstein M, et al. Biochem Pharmacol. 1977 Mar 15;26(6):477-80. doi: 10.1016/0006-2952(77)90320-3. Biochem Pharmacol. 1977. PMID: 849343 No abstract available.

7

New in vitro screening model for the discovery of antileukemic anticancer agents.

Valeriote F, Corbett T, Edelstein M, Baker L. Valeriote F, et al. Among authors: edelstein m. Cancer Invest. 1996;14(2):124-41. doi: 10.3109/07357909609018888. Cancer Invest. 1996. PMID: 8597898 No abstract available.

8

Synthesis and Biological Evaluation of Novel N-phenyl-5-carboxamidyl Isoxazoles as Potential Chemotherapeutic Agents for Colon Cancer.

Shaw J, Chen B, Bourgault JP, Jiang H, Kumar N, Mishra J, Valeriote FA, Media J, Bobbitt K, Pietraszkiewicz H, Edelstein M, Andreana PR. Shaw J, et al. Among authors: edelstein m. Am J Biomed Sci. 2012;4(1):14-25. doi: 10.5099/aj120100014. Am J Biomed Sci. 2012. PMID: 25285182 Free PMC article.

9

Cytosine arabinoside in experimental combination therapy.

Edelstein M, Valeriote F. Edelstein M, et al. Semin Oncol. 1985 Jun;12(2 Suppl 3):75-83. Semin Oncol. 1985. PMID: 3892705 Review. No abstract available.

10

Cellular quantitation of in vivo effects of 1-beta-D-arabinofuranosylcytosine on leukemia L1210.

Edelstein M, Valeriote F, Vietti T. Edelstein M, et al. J Natl Cancer Inst. 1977 Apr;58(4):941-7. doi: 10.1093/jnci/58.4.941. J Natl Cancer Inst. 1977. PMID: 845997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters